Syquant Capital’s Horizon Therapeutics HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
Syquant Capital's HZNP Position: Q4 2023 in Review
Syquant Capital sold out of Horizon Therapeutics (HZNP) in Q4 2023, closing a stake of 1,398,990 shares — an estimated $162M sold.
Syquant Capital first reported a position in HZNP in Q1 2023 and held it in 3 quarters. The position peaked at $162M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.
- Syquant Capital reported no remaining Horizon Therapeutics position as of Q4 2023 after selling out during the quarter.
- Syquant Capital sold 1,398,990 Horizon Therapeutics shares in Q4 2023, an estimated $162M.
- Syquant Capital first reported a position in Horizon Therapeutics in Q1 2023 and held it in 3 quarters.
- Syquant Capital's Horizon Therapeutics position peaked at $162M in Q3 2023.
- 6 funds tracked by Wall St. Rank held Horizon Therapeutics as of Q4 2023.
Based on Syquant Capital's 13F filing for Q4 2023, filed 10 Jan 2024.